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Abstract 
Hyperhomocysteinaemia and hypercholesterolaemia are implicated in pregnancy and various disease states and 
conditions including cardiovascular diseases. Their individual effects are known but the use of both in 
monitoring pregnancy. The aim of this study is thus the determination of serum Homocysteine  and cholesterol 
levels in pregnant Nigerian Women. Healthy fasting adult females had venepuncture while supine and without 
tourniquet. Homocysteine (tHcy), assay was done using ELISA assay with tHcy binding protein as the capturing 
enzyme. Excluded from the study were subjects with impaired renal function, liver function and diabetics. 
Subjects were 60(30 pregnant, 30 non pregnant). Their average age was 26.2 ± 1.7 (CI 0.05 25.6 – 26.8 95%) 
years for non pregnant controls and 30.7± 2.5 (CI 0.05 29.8 - 31.6 95%) years for those pregnant.  In the non 
pregnant group the Mean serum tHcy was 8.0 ± 4.0µmol/L (CI 0.05 6.6 – 9.4 95%). Three females had 
values >15µmol/L. In the pregnant group, Mean tHcy was 4.7 ± 0.9 µmol/L (CI 0.05 3.8 – 5.6 95%). 
Categorization of tHcy is as follows: <5µmol/L = 8/52(15%), 5-15µmol/L = 41/52(78.8%), >16µmol/L= 
3/52(5.7%).The mean tChol in the pregnant group was 3.26 ± 1.0mmol/L (CI 0.05 2.89 – 3.63) while that for the 
pregnant group was 4.82 ± 1.0 mmol/L (CI 0.05 4.45 – 5.19)  
Measuring tHcy and tChol in pregnancy is promising as a good index for monitoring pregnancy. There is a 
relationship between tHcy and tChol but this needs further investigation.  
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1. Introduction 
Hyperhomocysteinaemia has been linked in various studies worldwide to the occurrence of cardiovascular 
disorders, and endothelial cell injury (Holmes 2005). Hypertensive disorders in pregnancy (pre-
eclampsia/eclampsia) are among the leading causes of maternal mortality worldwide accounting for 
approximately 17% of all maternal deaths. Overall perinatal mortality in pre-eclampsia is about 35/1000 total 
births, but may reach 160/1000 births in severe cases. Pre-eclampsia complicates 3-5% of first pregnancy and 1-
2% of subsequent pregnancies with about 5-10% of cases being severe (Keinth 1999).  
Homocysteine (Hcy) is a thiol containing amino acid produced by the intracellular demethylation of the 
essential amino acid methionine. Intracellular Hcy either enters the transulphuration pathway or the 
remethylation cycle. Apparently 50% Hcy enters the transulphuration pathway, where it is irreversibly combined 
with Serine by the B6 dependent enzyme cystathionine beta-synthase to form Cysthathionine (Finkelstein 1990, 
Perry 1995). This is then metabolized to cysteine and ultimately to sulphate which is excreted in the urine. In the 
remethylation pathway, Hcy is recycled to methionine by two different reactions catalysed by betaine-Hcy 
metyltransferase and methionine synthase, which requires 5-methyltetrahydrofolate as methyl donor and vitamin 
B12 as a cofactor (Ueland 1995)
. 
When these enzymatic reactions involved in the two metabolic pathways of 
intracellular Hcy are impaired either due to genetic defects of enzymes for Hcy metabolism or the nutritional 
deficiency of vitamins such as Folate, B6 and B12, Hcy accumulates in the cells and is exported into the 
circulation (Malinow 1995). Approximately 80% of circulating Hcy in the blood is protein bound by disulphide 
linkage (Refsum 1985). The remaining unbound Hcy combines by oxidation either with itself to form the 
dimmer homocysteine or with cysteine to form the mixed disulphide cysteine-Hcy. Only a small amount 
circulates as free Hcy. Total Hcy (tHcy) represents the sum of all forms of Hcy including forms of oxidized, 
protein bound and free. 
Hyperlipidaemia has been well documented as a feature of pregnancy in many parts of the world. These 
findings are from different races (Taylor 1972, De Alvares 1967). Hyperlipidaemia, especially 
hypercholesterolaemia is frequently associated with hypertension, arteriosclerosis and pre-eclampsia. 
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Hyperlipdaemia may predispose the pregnant woman to diabetes mellitus. Singly or combined, this can lead to 
serious problems for the fetus, the mother or both of them. The mechanism of hyperlipidaemia of pregnancy is 
not fully understood. Genetics and race have been suggested as being pivotal in the aetiology of hyperlipidaemia 
of pregnancy. 
Hyperhomocysteinaemia is a sensitive marker of folate and cobalamin (vitaminB12) deficiency and an 
independent risk factor for cardiovascular disease. Plasma tHcy concentrations are also related to birth defects, 
pregnancy complications, Psychiatric disorders, and cognitive impairment in the elderly ( Savage  1994, Weir 
1998).  
Coexistence of hyperhomocysteinaemia and hypercholesterolaemia in a pregnancy can be a serious 
challenge to the care givers of the pregnant woman, the pregnant woman and the baby. Thus, the measurement of 
tHcy and lipid profiles in the clinical setting is thus of potentially great importance (Carmel 2001). 
Before diagnosis could be made using tHcy level, it is important to know the normal or reference level 
in the target population. There are some data in the Hcy field in Nigeria and there is an increased interest in this 
which is good. However, few data exist when it comes to data about lipids and homocysteine in pregnancy in the 
sub-Saharan Africa.  
In this study, we therefore looked at the relationship between serum lipids and tHcy in the Nigerian 
society with particular reference to healthy pregnant adult females. 
  
2. Materials and Methods 
Fifty pregnant females attending antenatal clinic at the Lagos University Teaching Hospital (LUTH) in 2004 
were randomly recruited. These were recruited in the third trimester of pregnancy. Fifty healthy age matched 
female adults were randomly recruited from among the staff of the college of medicine and the teaching hospital 
and students as controls. The exclusion criteria are; family history of diabetes mellitus, previous big babies 
(>5Kg), previous gestational diabetes, glycosuria, proteinuria, hypertension, obesity and previous history of pre-
ecclampsia or ecclampsia, with malignant diseases, acute infections, cardiovascular diseases, liver and renal 
disease. Clearance was obtained from the institutional ethical review committee and informed consent obtained 
from the subjects and controls. The subjects had venepuncture while supine and without tourniquet. Participants 
provided a complete medical history and were subjected to a thorough clinical examination. Collected blood 
(10ml) 5ml was transferred to disposable tubes containing Lithium Heparin and the other 5ml into tubes 
containing no anticoagulant and allowed to clot. After centrifugation at 3000rpm for 5minutes, the recovered 
plasma (from heparinized tubes) was emptied into dry plastic tubes and stored at –20
o
c until assayed. Serum was 
separated from the clotted sample into dry plastic tubes and equally stored frozen till analysis. Plasma 
homocysteine concentration was measured by Enzyme-linked Immunosorbent Assay (ELISA) using the micro-
well technique of the Diazyme laboratories,3550 General Atoms ct, San Diego, CA and expressed as  µmol/L 
(Frantzen 1998). Serum cholesterol was measured by an enzymatic method.   
 
3. Result 
Subjects were 60(30 pregnant, 30 non pregnant). Their average age was 26.2 ± 1.7 (CI 0.05 25.6 – 26.8 95%) 
years for non pregnant controls and 30.7± 2.5 (CI 0.05 29.8 - 31.6 95%) years for those pregnant.  In the non 
pregnant group the Mean serum tHcy was 8.0 ± 4.0µmol/L (CI 0.05 6.6 – 9.4 95%). Three females had 
values >15µmol/L. In the pregnant group, Mean tHcy was 4.7 ± 0.9 µmol/L (CI 0.05 3.8 – 5.6 95%). 
Categorization of tHcy is as follows: <5µmol/L = 8/52(15%), 5-15µmol/L = 41/52(78.8%), >16µmol/L= 
3/52(5.7%). 
The mean tChol in the pregnant group was 3.26 ± 1.0mmol/L (CI 0.05 2.89 – 3.63 95%) while that for the 
pregnant group was 4.82 ± 1.0 mmol/L (CI 0.05 4.45 – 5.19)   
Results were presented as mean ±SD. Pearson’s correlation coefficient® was used to show correlation between 
parameters. P ≤0.05 was considered statistically significant. 
  
4.  Discussion 
In this study, the mean serum total homocysteine (tHcy) was found to be significantly lower in the pregnant 
group, 4.7 vs 8.8 µmol/L [Table 1]. The mean total cholesterol (tChol) was however significantly higher in the 
pregnant group, 4.8 vs 3.3mmol/L. 
The finding of a lowered tHcy in the pregnant group is in agreement with many studies. Glew et al 
found a 30% lower mean tHcy in pregnant women compared with their non pregnant controls in Abuja, (7.1 vs 
10.1) Nigeria (Glew 2002). Walker and his group got tHcy at 36-42weeks gestation of 5.5(CI 3.3 7.5 95%), in 
the non pregnant control group they got 7.9(CI 6.2 9.6, 95%) (Walker 1999).  It has been widely accepted that 
tHcy only increase in pregnant women developing preeclampsia. This rise in tHcy in pregnancy has been linked 
with the formation of reactive oxygen species as well as the promotion of smooth muscle cell growth. Thus, a 
low level of tHcy in pregnancy is a good prognostication factor. 
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There have been conflicting reports about the behaviour of tChol in normal pregnancy. Some authors 
found a rise from 1
st 
through the 3
rd 
trimester of pregnancy while others found an initial rise from 1
st 
to 2
nd 
trimester and a fall in the 3
rd 
trimester (Sitadevi 1981, Brizzi 1999). Continuous rise throughout pregnancy has 
been found by earlier workers in Nigeria, United States of America, Asia and Europe (Ajose 2002). However, 
Das and Isichie, Adegoke and coworkers reported a fall in the third trimester (Das 1996, Adegoke 2003). It is 
known that in early pregnancy there is maternal fat accumulation but in the late phase of pregnancy maternal 
response to increased fetal demand ensures that fat which yields more energy per mole is utilized preferably to 
glucose. 
In this study, we found a tChol level of 3.3 in the non-pregnant controls and 4.8mmol/L in the pregnant 
group. This finding is comparable with that reported by Ajose (2002) and Ahaneku (1999) in the third trimester 
of pregnancy. 
The association between tHcy and tChol in pregnant group in this study shows a correlation of 0.2 
(r=0.2) while that between the tHcy and tChol in the non-pregnant controls was -0.4(r=-0.4). 
This may indicate that an increased tChol in presence of low tHcy may be a good prognostic tool in 
monitoring pregnancy. However, more studies are needed to fully establish the relationship between tHcy and 
tChol in pregnancy such that it can be used to monitor pregnancy effectively.  A longitudinal or cohort study 
involving a sizable number of pregnant women from 1
st 
through the third semester will be ideal. 
 
5. Conclusion 
 Measuring tHcy and tChol in pregnancy is promising as a good index for monitoring pregnancy. When the 
precise relationship is established alongside its aetiopathogenesis, it will be possible to introduce these tests in 
hospitals for the monitoring of pregnancy.    
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Table 1: Mean Age, tHcy and tChol in studied groups 
 Non Pregnant Pregnant 
Mean age (Yrs) 26.2
a
      3.5
b 
30.7
a
         5.0
b 
tHcy 8.0         8.0 4.7           4.8 
tChol 3.3         2.0 4.8           2.0 
 
Where a = mean values  
      b = 2SD 
    tHcy = total Homocysteine  
    tChol= total Cholesterol 
 
Fig 1: The association between tHcy and tChol in the non-pregnant control 
 
 
There is a correlation of -0.37 between tHcy and tChol in the pregnant women. 
 
Fig ii: The association between tHcy and tChol in non-pregnant controls 
 
There is a correlation of 0.2 between tHcy and tChol in the non pregnant control group. 
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